These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20706133)

  • 21. Short-Term Calorie Restriction in Early Life Attenuates the Development of Proteinuria but Not Glucose Intolerance in Type 2 Diabetic OLETF Rats.
    Nakano D; Diah S; Kitada K; Hitomi H; Mori H; Masaki T; Kobori H; Nishiyama A
    ISRN Endocrinol; 2011; 2011():768637. PubMed ID: 22282724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the renin angiotensin system in diabetic nephropathy.
    Chawla T; Sharma D; Singh A
    World J Diabetes; 2010 Nov; 1(5):141-5. PubMed ID: 21537441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
    Nistala R; Whaley-Connell A
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):53-8. PubMed ID: 23416840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.
    Ihara G; Kiyomoto H; Kobori H; Nagai Y; Ohashi N; Hitomi H; Nakano D; Pelisch N; Hara T; Mori T; Ito S; Kohno M; Nishiyama A
    J Hypertens; 2010 Nov; 28(11):2289-98. PubMed ID: 20706133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.
    Sofue T; Kiyomoto H; Kobori H; Urushihara M; Nishijima Y; Kaifu K; Hara T; Matsumoto S; Ichimura A; Ohsaki H; Hitomi H; Kawachi H; Hayden MR; Whaley-Connell A; Sowers JR; Ito S; Kohno M; Nishiyama A
    Am J Hypertens; 2012 May; 25(5):604-11. PubMed ID: 22318512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.
    Nishiyama A; Kobori H; Konishi Y; Morikawa T; Maeda I; Okumura M; Kishida M; Hamada M; Nagai Y; Nakagawa T; Ohashi N; Nakano D; Hitomi H; Imanishi M
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1072-80. PubMed ID: 19940106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CS-886, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
    Koga K; Yamagishi S; Takeuchi M; Inagaki Y; Amano S; Okamoto T; Saga T; Makita Z; Yoshizuka M
    Mol Med; 2002 Oct; 8(10):591-9. PubMed ID: 12477969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).
    Ogihara T; Kikuchi K; Matsuoka H; Fujita T; Higaki J; Horiuchi M; Imai Y; Imaizumi T; Ito S; Iwao H; Kario K; Kawano Y; Kim-Mitsuyama S; Kimura G; Matsubara H; Matsuura H; Naruse M; Saito I; Shimada K; Shimamoto K; Suzuki H; Takishita S; Tanahashi N; Tsuchihashi T; Uchiyama M; Ueda S; Ueshima H; Umemura S; Ishimitsu T; Rakugi H;
    Hypertens Res; 2009 Jan; 32(1):3-107. PubMed ID: 19300436
    [No Abstract]   [Full Text] [Related]  

  • 31. Regression of glomerular injury by losartan in experimental diabetic nephropathy.
    Teles F; Machado FG; Ventura BH; Malheiros DM; Fujihara CK; Silva LF; Zatz R
    Kidney Int; 2009 Jan; 75(1):72-9. PubMed ID: 18946500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
    Nishiyama A; Nakagawa T; Kobori H; Nagai Y; Okada N; Konishi Y; Morikawa T; Okumura M; Meda I; Kiyomoto H; Hosomi N; Mori T; Ito S; Imanishi M
    J Hypertens; 2008 Sep; 26(9):1849-59. PubMed ID: 18698221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of mesangial cell alpha-smooth muscle actin expression in 3-dimensional matrix by high glucose and growth factors.
    Whiteside C; Munk S; Ispanovic E; Wang H; Goldberg H; Kapus A; Xia L
    Nephron Exp Nephrol; 2008; 109(2):e46-56. PubMed ID: 18600029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteinuria in diabetic kidney disease: a mechanistic viewpoint.
    Jefferson JA; Shankland SJ; Pichler RH
    Kidney Int; 2008 Jul; 74(1):22-36. PubMed ID: 18418356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of remission clinics in the longitudinal treatment of CKD.
    Ruggenenti P; Perticucci E; Cravedi P; Gambara V; Costantini M; Sharma SK; Perna A; Remuzzi G
    J Am Soc Nephrol; 2008 Jun; 19(6):1213-24. PubMed ID: 18354029
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.